Launch a bold, basic-science clinical trial without preliminary data. The NIH Stephen I. Katz R01 (BESH) funds Early Stage Investigators to pursue a clear change in research direction using prospective human experiments aimed at fundamental discovery.
Eligibility Criteria
-
PD/PI must be an NIH-designated Early Stage Investigator (all MPIs must be ESIs).
-
Project must be a new research direction; attach a one-page “New Research Direction.”
-
No unpublished preliminary data allowed.
-
Eligible U.S. applicant types: higher education, nonprofits, small businesses/for-profits, and eligible public entities; foreign organizations/components not allowed.
-
Required registrations: SAM (UEI), eRA Commons, Grants.gov.
Funding Details
-
Mechanism: R01 (BESH — clinical trial required; basic research).
-
Budget: Not limited; must match project needs (≥500,000 USD direct costs/year requires prior contact).
-
Project period: Up to 5 years.
-
Application types: New; Resubmission.
Deadline
-
Standard cycles through 2028; first due date: September 26, 2025 (5:00 PM local).
-
FOA expires August 26, 2028.
Where to Go for Further Information
-
Help: [email protected].